- NVAX -1.83%
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Yahoo Finance · 6 days ago
Open | 4.9300 |
High | 5.0400 |
Low | 4.8120 |
Mkt Cap | 679.54M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 4.9300 |
52 Wk. Low | 3.5300 |
52 Wk. High | 11.3600 |
Related stocks
Company in Gaithersburg, Maryland
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 291.34M | 18.50% ▼ |
Net Income | -178.39M | - |
Diluted EPS | -1.44 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | -$1.06 | - |
Q4 2023 | -$0.45 | -$1.44 |
Q3 2023 | -$1.83 | -$1.26 |
S&P 500^GSPC | 5,169.36+41.57 (+0.81%) |
Dow 30^DJI | 38,777.23+101.55 (+0.26%) |
Nasdaq^IXIC | 16,309.71+153.38 (+0.95%) |
25.25+8.23% | |
5.11+13.56% | |
20.69+18.10% |